文献速递主动脉疾病

腰大肌面积作为腹主动脉瘤腔内修复转换术患者生存的预后因素

Psoas Muscle Area as a Prognostic Factor for Survival in Patients Undergoing Endovascular Aneurysm Repair Conversion.
PubMed 文献 · Ann Vasc Surg · 2022-09-01

该单中心回顾性研究分析了2002至2019年间153例腹主动脉瘤腔内修复转换术(EVAR-c)患者,以L3椎体中部横断面腰大肌面积(PMA)最低三分位定义为低PMA组(n=51),与正常PMA组(n=102)比较。低PMA组住院死亡率和并发症更高、1年和5年生存率更低,PMA每增加100 mm2全因死亡风险降低15%(HR 0.85,95%CI 0.74-0.97;P=0.02)。作者认为PMA评估可作为EVAR-c传统风险分层策略的辅助手段。

要点

  • 低PMA组住院死亡率16% vs 正常PMA组5%(P=0.02),总并发症数1.5±1.9 vs 0.9±1.5(P=0.02)。
  • 低PMA组出院时持续需要血液透析18% vs 4%(P=0.01)。
  • 低PMA组1年和5年生存率分别为77±5%、65±6%,低于正常PMA组的86±3%、82±5%(log-rank P=0.03)。

核心结论

  • 在EVAR-c患者中,术前低PMA者术后并发症发生率更高且总生存更差。
  • PMA评估可能作为传统风险分层策略的辅助手段,用于考虑EVAR-c的患者。

研究设计与样本

  • 回顾性单中心研究,分析2002至2019年间所有腹主动脉瘤修复中的EVAR-c手术(n=153)。
  • 测量L3椎体中部横断面PMA,以最低三分位为阈值定义低PMA组(n=51),与正常PMA组(n=102)比较。
  • 采用Cox比例风险模型评估协变量与全因死亡的关联。

主要发现

  • 低PMA组年龄77 vs 正常PMA组72岁(P=0.002),女性27% vs 5%(P<0.001),体重指数26 vs 29 kg/m2(P=0.002)。
  • 低PMA组动脉瘤直径8.3 vs 7.5 cm(P=0.01),EVAR术后瘤囊增长2.3 vs 1 cm(P=0.005)。
  • 低PMA组住院死亡率16% vs 正常PMA组5%(P=0.02),总并发症数1.5±1.9 vs 0.9±1.5(P=0.02)。
  • 低PMA组出院时持续需要血液透析18% vs 4%(P=0.01)。
  • 低PMA组1年和5年生存率分别为77±5%、65±6%,正常PMA组分别为86±3%、82±5%(log-rank P=0.03)。

关键数值与推荐

  • PMA每增加100 mm2与全因死亡风险降低15%独立相关(HR 0.85,95%CI 0.74-0.97;P=0.02)。
  • 低PMA定义为PMA最低三分位(n=51),正常PMA为其余患者(n=102)。

临床怎么用

  • 作者认为,PMA评估可能作为传统风险分层策略的辅助手段,用于考虑EVAR-c的患者。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Endovascular aneurysm repair conversion (EVAR-c) is increasingly reported and known to be technically complex and physiologically demanding. It has been proposed that pragmatic anthropomorphic measures such as psoas muscle area (PMA) may reliably quantify levels of preoperative frailty and be used to inform point of care clinical decision-making and patient discussions for a variety of complex operations. To date, there is mixed data supporting use of PMA as a prognostic factor in fenestrated endovascular and open abdominal aortic aneurysms (AAA) repairs; however, no literature exists evaluating the impact of preoperative PMA on EVAR-c results. Therefore, the purpose of this study was to review our EVAR-c experience and evaluate the association of PMA with perioperative and long-term mortality outcomes. METHODS: A retrospective single-center review of all AAA repairs was performed (2002-2019) and EVAR-c procedures were subsequently analyzed (n = 153). Cross-sectional PMA at the mid-body of the L3 vertebrae was measured. The lowest PMA tertile was used as a threshold value to designate patients as having "low" PMA (n = 51) and this cohort was subsequently compared to subjects with "normal" PMA (n = 102). Cox proportional hazards modeling was used to estimate covariate association with all-cause mortality. RESULTS: Patients with low PMA were older (77 vs. 72 years; P = 0.002), more likely to be female (27% vs. 5%; P < 0.001), and had reduced body mass index (26 vs. 29 kg/m2; P = 0.002). Time to conversion, total number of endovascular aneurysm repair (EVAR) reinterventions prior to conversion and elective EVAR-c presentation incidence were similar; however, patients with low PMA had larger aneurysms (8.3 vs. 7.5 cm; P = 0.01) and increased post-EVAR sac growth (2.3 vs. 1 cm; P = 0.005). Unadjusted inpatient mortality was significantly greater for low PMA patients (16% vs. normal PMA, 5%, P = 0.02). Similarly, the total number of complications was higher among low PMA subjects (1.5 ± 1.9 vs. normal PMA, 0.9 ± 1.5; P = 0.02). Although frequency of major adverse cardiovascular events and new onset inpatient hemodialysis were similar, low PMA patients had a more than four-fold increased likelihood of having persistent requirement of hemodialysis at discharge (18% vs. 4%,P = 0.01). The low PMA group had decreased survival at 1 and 5 years, respectively (77 ± 5%, 65 ± 6% vs. normal PMA, 86 ± 3%, 82% ± 5%; log-rank P = 0.03). Low PMA was an independent predictor of mortality with every 100 mm2 increase in PMA being associated with a 15% reduction in mortality (hazard ratio: 0.85,95% confidence interval:, 0.74-0.97; P = 0.02). CONCLUSIONS: Among EVAR-c patients, subjects with low preoperative PMA had higher rates of postoperative complications and worse overall survival. PMA assessments may be a useful adjunct to supplement traditional risk-stratification strategies when patients are being considered for EVAR-c.

来源:Ann Vasc Surg,查看原文。版权归原作者所有。

引用

  1. Jacobs CR, Scali ST, Filiberto A, et al. Psoas Muscle Area as a Prognostic Factor for Survival in Patients Undergoing Endovascular Aneurysm Repair Conversion. Ann Vasc Surg. 2022. PMID: 36058454. doi:10.1016/j.avsg.2022.08.001

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。